Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia: a pilot study from the Gimema Group
M. Montillo et al., Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia: a pilot study from the Gimema Group, BR J HAEM, 111(1), 2000, pp. 334-337
Elderly patients with untreated acute myeloid leukaemia (AML, n = 47) teste
d the feasibility of out-patient consolidation therapy and post-consolidati
on treatment (for patients aged < 71 years) with autologous peripheral bloo
d stem cell transplantation (APBSCT). Overall, 13 patients out of 24 (51%)
who achieved complete remission (CR) were eligible for further treatment af
ter consolidation. Five patients were primed with granulocyte colony stimul
ating factor (G-CSF); a suitable number of CD34(+) cells were harvested in
three patients and were actually autotransplanted. The toxicity of APBSCT w
as negligible, Psychosocial problems impaired treatment: of some patients o
n an out-patient basis. Resistant disease, toxicity and logistic problems r
educed the number of patients to whom this procedure could actually be appl
ied.